Publications

Rosen MI, Kosten T: Cocaine-associated panic attacks in methadone-maintained patients. American Journal of Drug and Alcohol Abuse, 1992; 18(1): 57-62.

Rosen MI, Bridge TP, O'Malley SS, Pearsall HR, Martini B, O'Connor PG, Brett-Smith H, Thomas HM, van Dyck CH, Woods SW, Kosten TR: Peptide T treatment of cognitive impairment in HIV-positive intravenous drug users. The American Journal on Addictions, 1992; 1(3): 1-7.

Jenkins SW, Warfield NA, Blaine JD, Cornish J, Ling W, Rosen MI, Urschel H, Wesson D, Ziedonis D: A pilot trial of gepirone vs. placebo in the treatment of cocaine dependency. Psychopharmacology Bulletin, 1992; 28(1): 21-26.

Rosen MI, Pearsall HR, McDougle CJ, Price LH, Woods SW, Kosten TR: Effects of acute buprenorphine on responses to intranasal cocaine: a pilot study. American Journal of Drug and Alcohol Abuse, 1993; 19(4): 451-464.

Rosen MI, Pearsall HR, Price LH, McDougle CJ, Woods SW, Kosten TR: Carbamazepine vs. oxazepam for benzodiazepine detoxification in methadone-maintained patients. The American Journal on Addictions, 1993; 2(2): 165-168.

Rosen MI, Wallace EA, McMahon TJ, Pearsall HR, Woods SW, Price LH, Kosten TR: Buprenorphine: duration of blockade of effects of intramuscular hydromorphone. Drug and Alcohol Dependence, 1994; 35: 141-149.

van Dyck CH, Rosen MI, Thomas HM, McMahon TJ, Wallace EA, O’Connor PG, Sullivan M, Krystal JH, Hoffer PB, Woods SW, Kosten TR: SPECT regional cerebral blood flow alterations in naltrexone-precipitated withdrawal from buprenorphine. Psychiatry Research: -Neuroimaging 1994; 55: 181-191.

Oliveto AH, Rosen MI, Woods SW, Kosten TR: Discriminative stimulus, self-reported and cardiovascular effects of orally-administered cocaine in humans. The Journal of Pharmacology and Experimental Therapeutics, 1995; 272(1): 231-234.

Krystal JH, Woods SW, Kosten TR, Rosen MI, Seibyl JP, van Dyck CC, Price LH, Zubal IG, Hoffer PB, Charney DS: Opiate dependence and withdrawal; preliminary assessment using single photon emission computerized topography (SPECT). American Journal of Drug and Alcohol Abuse, 1995; 21(1): 47-63.

Hameedi FA, Rosen MI, McCance-Katz EF, McMahon TJ, Price LH, Jatlow PI, Woods SW, Kosten TR: Behavioral, physiological and pharmacological interaction of cocaine and disulfiram. Biological Psychiatry, 1995; 34: 560-563.

Rosen MI, McMahon TJ, Margolin A, Gill TS, Woods SW, Pearsall HR, Kreek MJ, Kosten TR: Reliability of sequential naloxone challenge tests. American Journal of Drug and Alcohol Abuse, 1995; 21(4): 453-467.

Kosten TA, DeCaprio JL, Rosen MI: The severity of naloxone-precipitated opiate withdrawal is attenuated by the glycine agents felbamate and d-cycloserine. Neuropsychopharmacology, 1995; 13(4): 323-333.

Rosen MI, Pearsall HR, Woods SW, Kosten TR: The effect of gamma-hydroxybutyric acid on naloxone-precipitated opiate withdrawal. Neuropsychopharmacology, 1996; 14(3): 187-193.

Rosen MI, McMahon TJ, Hameedi FA, Pearsall HR, Woods SW, Kreek MJ, Kosten TR: Effect of clonidine pretreatment on naloxone-precipitated opiate withdrawal. The Journal of Pharmacology and Experimental Therapeutics, 1996; 276(3): 1128-1135.

Rosen MI, McMahon TJ, Woods SW, Pearsall HR, Kosten TR: A pilot study of dextromethorphan in naloxone-precipitated opiate withdrawal. European Journal of Pharmacology, 1996; 307(3): 251-257.

Kosten TR, Kosten TA, McDougle CJ, Hameedi FA, McCance EF, Rosen MI, Oliveto AH, Price LH: Gender differences in response to intranasal cocaine administration to humans. Biological Psychiatry, 1996; 39: 147-148.

Wallace EA, Wisniewski G, Zubal G, van Dyck CH, Pfau SE, Smith EO, Rosen MI, Sullivan MC, Woods SW, Kosten TR: Acute cocaine effects on absolute cerebral blood flow.  Psychopharmacology, 1996; 128(1): 17-20.

Hameedi FA, Woods SW, Rosen MI, Pearsall HR, Kosten TR: Dose dependent effects of yohimbine on methadone maintained patients. American Journal of Drug and Alcohol Abuse, 1997; 23(2): 327-333.

Rosen MI, Pearsall HR, Woods SW, Kosten TR: Effects of gamma-hydroxybutyric acid (GHB) in opioid-dependent patients. Journal of Substance Abuse Treatment, 1997; 14(2): 1-6.

van Dyck CH, McMahon TJ, Rosen MI, O'Malley SS, O'Connor PG, Lin CH, Pearsall HR, Woods SW, Kosten TR: Sustained-release methylphenidate for cognitive impairment in HIV-infected drug abusers: A pilot study. Journal of Neuropsychiatry and Clinical Neurosciences, 1997; 9: 29-36.

Hoffman RE, Esposito R, Rosen MI, Rockholz P: Recurrent personal memories during intoxication reported by patients with alcoholism. Psychological Medicine, 1997; 27: 1441-1446.

Kosten TR, Rosen MI, Bridge TP, O'Malley SS, Pearsall HR, McMahon TJ, O'Connor PG: Treatment of early AIDS dementia in intravenous drug users: High versus low dose peptide T. American Journal of Drug and Alcohol Abuse, 1997; 23(4): 543-553.

Rosen MI, Pearsall HR, Kosten TR: The effect of lamotrigine on naloxone-precipitated opiate withdrawal. Drug and Alcohol Dependence, 1998; 52: 173-176.

Oliveto AH, Rosen MI, Kosten TA, Hameedi F, Woods SW, Kosten TR: Naloxone discrimination in opioid-dependent subjects under a novel-response discrimination procedure. Journal of Experimental and Clinical Psychopharmacology, 1998; 6(2): 169-178.

Rosen MI and Rosenheck R: Substance use and the assignment of representative payees. Psychiatric Services, 1999; 50: 95-98.

Rosen MI, Kosten TR, Kreek MJ: The effect of naltrexone maintenance on the response to yohimbine. Biological Psychiatry 1999; 45 (12): 1636-1645.

Winther LC, Saleem R, McCance-Katz EF, Rosen MI, Hameedi FA, Pearsall HR, Jatlow PI, Kosten TR, Woods SW: Effect of lamotrigine on behavioral and cardiovascular responses to cocaine in human subjects. American Journal of Drug and Alcohol Abuse 2000; 26 (1): 47-59.

Krishnan-Sarin S, Rosen MI, O’Malley SS: Naloxone challenge in smokers: preliminary evidence of an opioid component in nicotine dependence. Archives of General Psychiatry 1999; 56: 663-668.

Kosten TR, Woods SW, Rosen MI, Pearsall HR: Interactions of cocaine with nimodipine: a brief report. American Journal on Addiction 1999; 8: 77-81.

Farren CK, Hameedi FA, Rosen MI, Woods S, Jatlow P, Kosten TR: Significant interaction between clozapine and cocaine in cocaine addicts. Drug and Alcohol Dependence 2000; 159 (2): 153-163.

Rigsby MO, Rosen MI, Beauvais JE, Cramer JA, Rainey PM, O’Malley SS, Dieckhaus KD, Rounsaville BJ: Cue-dose training with monetary reinforcement: pilot study of an antiretroviral adherence intervention. Journal of General Internal Medicine 2000; 15: 841-847.

Rosen MI, Desai R, Bailey M, Davidson L, Rosenheck R: Consumer experience with payeeship provided by a CMHC. Psychiatric Rehabilitation Journal 2001; 25 (2): 190-195.

Kosten TR, Rosen M, Bond J, Settles M, Roberts JS, Shields J, Fox B: Human cocaine vaccine: safety and immunogenicity. Vaccine 2002; 20 (7-8): 1196-1204.

Rosen MI, Rigsby MO, Dieckhaus KD, Cramer J: Effects of illicit drug use on adherence to prescribed antiretroviral medication. American Journal on Addiction 2003; 12 (5): 455-458.

Rosen MI, Rosenheck R, Shaner A, Eckman T, Gamache G, Krebs C: Veterans who may need a payee to prevent misuse of funds for drugs. Psychiatric Services 2002; 53 (8): 995-1000.

Rosen MI, Rosenheck R, Shaner A, Eckman T, Gamache G, Krebs C: Substance abuse and the need for money management assistance among psychiatric inpatients. Drug and Alcohol Dependence 2002; 67 (3): 331-334.

Rosen MI, Rosenheck R, Shaner A, Eckman T, Gamache G, Krebs C: Payee relationships: institutional payees versus personal acquaintances. Psychiatric Rehabilitation Journal 2003; 26 (3): 262-267.

Rosen MI, Bailey M, Rosenheck RA: Principles of Money Management As a Therapy for Addiction. Psychiatric Services 2003; 54 (2): 171-173.

Rosen MI, Ryan C, Rigsby MO: Motivational Enhancement and MEMS Review to Improve Medication Adherence. Behaviour Change 2002; 19 (4): 183-190.

Rosen MI, Beauvais JE, Rigsby MO, Salahi J, Ryan C, Cramer JA: Neuropsychological correlates of sub-optimal adherence to metformin. Journal of Behavioral Medicine 2003; 26 (4): 349-360.

Rosen MI, Rosenheck R, Shaner A, Eckman T, Gamache G, Krebs C: Do patients who mismanage their funds use more health services? Administration and Policy in Mental Health 2003; 31 (2): 131-140.

Rosen MI, Rigsby MO, Salahi JT, Ryan CE, Cramer JA: Electronic monitoring and counseling to improve medication adherence. Behaviour Research and Therapy 2004; 42 (4): 409-422.

Rosen MI, Bailey M, Dombrowski E, Ablondi K, Rosenheck RA: A comparison of satisfaction with clinician, family members/friends and attorneys as payees. Community Mental Health Journal 2005; 41 (3): 291-306.

Rosen MI, McMahon TJ, Lin HQ, Rosenheck RA: Effect of Social Security Payments on Substance Abuse in a Homeless Mentally Ill Cohort. Health Services Research 2006; 41 (1): 173-191.

Rosen MI, McMahon TJ, Rosenheck RA: Does assigning a representative payee reduce substance abuse? Drug and Alcohol Dependence 2007; 86 (2-3): 115-122.

Rosen MI, Dieckhaus K, McMahon TJ, Valdes B, Petry NM, Cramer J, Rounsaville B: Improved adherence with contingency management. AIDS Patient Care & STDs; 2007; 21 (1): 30-40.

Rosen MI, McMahon TJ, Rosenheck RA: Homeless people whose self-reported SSI/SSDI status is inconsistent with Social Security Administration records. Social Security Bulletin 2007; 67 (1): 53-62.

Black, R.A., Rounsaville, B.J., Rosenheck, R.A., Conrad, K.C., Ball, S.A., Rosen M.I.: Measuring money mismanagement among dually diagnosed clients. Journal of Nervous and Mental Disorders 2008; 196: 576-579. NIHMSID 165779, PMCID 2804268.

Rosen MI, Carroll KM, Stefanovics EA, Rosenheck RA: A Randomized Controlled Trial of a Money-Management Based Intervention Targeting Substance Use. Psychiatric Services 2009; 60(4): 498-504. PMC2831204.

Black RA, Serowik KL, Rosen MI: Associations between Impulsivity and High Risk Sexual Behaviors in Dually Diagnosed Outpatients. American Journal of Drug and Alcohol Abuse 2009; 35 (5): 328-328.

Le T, Chiarella J, Simen BB, Hanczaruk B, Egholm M, Landry ML, Dieckhaus K, Rosen MI, Kozal MJ: Low-Abundance HIV Drug-Resistant Viral Variants in Treatment-Experienced Persons Correlate with Historical Antiretroviral Use. PLoS (Public Library of Science) ONE 2009; 4(6):e6079. PMCID 2698118.

Contardo C, Beauvais JE, Dieckhaus KD, Rosen MI: Relationship of Prospective Memory to Neuropsychological Function and Antiretroviral Adherence. Archives of Clinical Neuropsychology 2009; 24(6):547-54. PMCID 2764502.

Rosen MI, Rounsaville BJ, Ablondi K, Black AC, Rosenheck RA: Advisor-Teller Money Manager (ATM) Therapy for Substance Abuse. Psychiatric Services 2010; 61(7): 707-713. PMID: 20592006.

Rosen MI: Compensation Examinations for PTSD—an Opportunity for Treatment? Journal of Rehabilitation Research and Development 2010; 47(5): 15-22.

Black AC, Rosen MI: A Money Management-Based Substance Use Treatment Increases Valuation of Future Rewards. Addictive Behaviors 2011; 36: 125-128.

Fries H, Rosen MI: The Efficacy of Assertive Community Treatment to Treat Substance Use. Journal of the American Psychiatric Nurses Association 2011; 17: 45-50.

McQuaid JR, Marx BP, Rosen MI, Bufka LF, Tenhula W, Cook H, Keane TM: Mental Health Assessment in Rehabilitation Research. Journal of Rehabilitation Research and Development 202; 49: 121-138.

Black AC, Serowik KL, Schensul JJ, Bowen, AM, Rosen MI: Build a Better Mouse: Directly-Observed Issues in Computer Use for Adults with SMI. Psychiatric Quarterly 2012; 10.1007/s11126-012-9229-z

Black AC, Serowik KL, Ablondi K, Rosen MI: Timeline Historical Review of Income and Financial Transactions: A Reliable Assessment of Personal Finances. Journal of Nervous & Mental Disease 2013; 201: 56-59.